What were the results of the PROTECT AF Trial regarding the safety of percutaneous left atrial appendage closure?
The PROTECT AF Trial concluded that the percutaneous left atrial appendage closure was safe, with no reported deaths or major adverse events related to the device. Additionally, the trial found that the device was effective in reducing the risk of stroke in patients with atrial fibrillation compared to those taking warfarin.